Cadonilimab(AK104) Plus Concurrent Chemoradiotherapy in Patients With Locally Advanced, Unresectable, Stage III NSCLC
Clinical trial NCT06448910 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06448910
- Sponsor
- Fudan University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2025-10-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.